Responses
Clinical and epidemiological research
Extended report
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)
Compose a Response to This Article
Other responses
No responses have been published for this article.